Study on the treatment outcomes of advanced laryngeal and hypopharyngeal cancer with induction chemotherapy-Reference-Cited by-同舟云学术

Study on the treatment outcomes of advanced laryngeal and hypopharyngeal cancer with induction chemotherapy

Published:2023 Issue:3 Volume:49 Page:249-254
ISSN:1349-5747
Container-title:Toukeibu Gan
language:en
Short-container-title:Toukeibu Gan

Author:

Uryu Hideoki¹,Tamura Shingo¹,Kitagawa Rina¹,Koide Ayaka¹,Hara Kaori¹,Uchi Ryutaro¹,Nakashima Torahiko¹

Affiliation:

1. Department of Otorhinolaryngology, Clinical Oncology, Clinical Research Center, National Hospital Organization Kyushu Medical Center

Publisher

Japan Society for Head and Neck Cancer

Subject

Oncology,Otorhinolaryngology

Link

https://www.jstage.jst.go.jp/article/jjhnc/49/3/49_249/_pdf

Reference14 articles.

1. 1） National Comprehensive Cancer Network （NCCN）: Clinical Practice Guidelines in Oncology for Head and Neck Cancers, Version 3,2021. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

2. 2） European Society for Medical Oncology （ESMO）: Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up for Head and Neck Squamous Cell Carcinoma. https://www.esmo.org/guidelines/head-and-neck-cancers/diagnosis-treatment-and-follow-up-for-head-and-neck-squamous-cell-carcinoma.

3. 3） Bourhis J., Overgaard J., Audry H., et al: Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368（9538）：843-854, 2006

4. 4） Posner M.R., Hershock D.M., Blajman C.R., et al: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. New England Journal of Medicine 357（17）：1705-1715, 2007

5. 5） Vermorken J.B., Remenar E., van Herpen C., et al: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. New England Journal of Medicine 357（17）：1695-1704, 2007